AlphaCopdDoc Profile Banner
Alice Turner Profile
Alice Turner

@AlphaCopdDoc

Followers
1K
Following
2K
Media
131
Statuses
1K

Professor & Consultant Respiratory Med, @PSRC_Midlands director. @NRAPaudit #QI lead. @AlphaFriend board member. Clinical & research #AATD #COPD.

University of Birmingham
Joined January 2016
Don't wanna be here? Send us removal request.
@DrLoomba
Rohit Loomba
7 days
Great collaborative effort @AmerGastroAssn @AASLDPresident @EASLnews Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (AATD-LD) https://t.co/El4ZmhllUm
2
7
19
@NRAPaudit
National Respiratory Audit Programme
7 days
📢One week left to apply for @NRAPaudit healthcare improvement clinical fellow. @ARNS_UK @BTSrespiratory @PRaccreditation For further information and how to apply visit: https://t.co/RMNB6qE5J7
0
3
2
@PeerVoice
PeerVoice
2 months
Missed our recent #AATD live event from Amsterdam? Watch the onDemand video to get insights on proactive screening, cross-specialty collaboration, and the current treatment landscape. #PeerVoice #meded #AATD #pulmonology #hepatology https://t.co/VPSE5Smbt5
0
2
2
@AlphaFriend
Alpha-1 Foundation
2 months
The A1F team kicked off #Alpha1Awareness Month and the A1F Virtual Walk 2025 together at our Coral Gables office! The energy is high and we are ready for a month of awareness, advocacy, and community. Join us and be part of the movement: https://t.co/K6ZnxIx5nV
0
1
1
@WMPA_UK
West Midlands Physicians Association
2 months
Here’s a reminder of the #WMPAMatMed programme happening at UHCW next month Features talks on chest pain, headache and endocrine emergencies, plus research abstracts, case reports and posters in adult general internal medicine Register here: https://t.co/cebyEdKryI
0
2
0
@AlphaCopdDoc
Alice Turner
2 months
Great day with @NIHRPSRCs discussing safety equity. Loved the live graphics summarising talks (@PSRC_Midlands highlights 👇🏻) and the summary of maternal care pathway through an equity lens
1
2
7
@ATSBlueEditor
ATS Blue Journal
2 months
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD @atscommunity đź”— https://t.co/08LyOFDFSi
0
3
4
@AlphaCopdDoc
Alice Turner
3 months
Great talk on microplastics & lung health #ERSCongress2025 Key messages - more ingestion from air than gut, thus most deposition in the lung. Links to #COPD & ILD. The type of plastic matters
0
2
4
@AlphaCopdDoc
Alice Turner
3 months
Methods to prevent respiratory disease and it's impacts, from #airquality interventions, case finding, lifestyle & more - summarised by @WHO in this report focussed on Europe #ERSCongress2025
Tweet card summary image
who.int
0
0
0
@AlphaCopdDoc
Alice Turner
3 months
Shifting thinking toward prevention as the most cost-effective strategy in #copd Sounds sensible but not easy in many health systems #ERSCongress2025
0
0
1
@AlphaCopdDoc
Alice Turner
3 months
Dupilumab for ABPA - signals for FEV1, possibly exacerbations, & QOL #ERSCongress2025
0
0
6
@YHPSRC
NIHR Yorkshire and Humber PSRC
3 months
Join us for our next SafetyNet webinar: Understanding and measuring emergency doctors’ tolerance of clinical uncertainty on Wednesday 12 November 🔗Book your place: https://t.co/7Sg8pnFZp1... @drwilliamlea @NIHRPSRCs #emergencymedicine
0
7
4
@AlphaCopdDoc
Alice Turner
3 months
ALIENTO study of Astegolimab, targeting IL33 in #COPD. Marginal effect on AECOPD, direction same as (negative) ARNASA study. Maybe too broad/late population? #ERSCongress2025
0
0
3
@AlphaCopdDoc
Alice Turner
3 months
Started #ERSCongress2025 with an excellent NTM session. Take homes: many new routes to Rx, CFTR & GM-CSF clinical data promising. BACES score aids prognostication
0
0
4
@Rubagumyaf
Fidel Rubagumya , MD, MMed, MPH
3 months
"We" need clinical trials & translational research, but the urgent gap is in health services & implementation science. We know much of what works; the challenge is delivering it equitably, affordably, and sustainably. Research must meet reality.
0
11
28
@ProfJDChalmers
James D Chalmers
4 months
Treatable traits! New! We compare inflammation, microbiome, rheology and mucins in asthma, COPD, bronchiectasis, CF and controls. Huge overlap in biology but clear neutrophilic and T2 endotypes in all diseases! Endotypes>disease labels @accpchest https://t.co/61KzACwcGt
2
28
79
@journal_CHEST
CHEST® Journal
4 months
Original research shows that preserved ratio impaired spirometry (PRISm) was associated with transition into airway obstruction corresponding to #COPD within one decade. Read more in the August issue of the journal CHEST®: https://t.co/gcDSUxZShA #MedEd #JournalCHEST
0
12
23
@NHSGIRFT
Getting It Right First Time (GIRFT)
4 months
🚑 Maximising Ambulance Referrals into virtual wards via Single Point of Access (SPOA). Dr Shelagh O’Riordan will be in conversation with ambulance & A&E colleagues exploring streamlining ambulance referrals into virtual care. 📅 Register: https://t.co/ql9SwTZaED @jupiterhouse1
0
6
4